Page last updated: 2024-11-06

prednisolone and Craniomandibular Diseases

prednisolone has been researched along with Craniomandibular Diseases in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Reduction in jaw opening is a neglected symptom of giant cell arteritis (GCA) in clinical practice and in the scientific literature."7.77Reduction in jaw opening: a neglected symptom of giant cell arteritis. ( Berlit, P; Herold, M; Kraemer, M; Metz, A; Venker, C, 2011)
"Reduction in jaw opening is a neglected symptom of giant cell arteritis (GCA) in clinical practice and in the scientific literature."3.77Reduction in jaw opening: a neglected symptom of giant cell arteritis. ( Berlit, P; Herold, M; Kraemer, M; Metz, A; Venker, C, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kraemer, M1
Metz, A1
Herold, M1
Venker, C1
Berlit, P1

Other Studies

1 other study available for prednisolone and Craniomandibular Diseases

ArticleYear
Reduction in jaw opening: a neglected symptom of giant cell arteritis.
    Rheumatology international, 2011, Volume: 31, Issue:11

    Topics: Aged; Craniomandibular Disorders; Diagnostic Errors; Female; Giant Cell Arteritis; Glucocorticoids;

2011